COVID-19 trials registries data warehouse

 Return to trial list

Trial - NCT05668039


Column Value
Trial registration number NCT05668039
Full text link
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

First author
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

Dafna Yahav, MD

Contact
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

Dafna.Yahav@sheba.health.gov.il

Registration date
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

2022-12-29

Recruitment status
Last imported at : Dec. 1, 2023, 8 a.m.
Source : ClinicalTrials.gov

Recruiting

Study design
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

RCT

Allocation
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

Randomized

Design
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

Parallel

Masking
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

Blind label

Center
Last imported at : Dec. 1, 2023, 8 a.m.
Source : ClinicalTrials.gov

single-center

Study aim
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

Long covid

Inclusion criteria
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

inclusion criteria: patients recovering from pcr or lateral flow testing proven acute covid-19 3-12 months following the acute infection suffering from fatigue with a promis-sf-7a t-score of > 50

Exclusion criteria
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

acute decompensated heart failure recent myocardial infarction within the last 3 months unstable angina pectoris severe hypertension > 180/110 mm hg coagulopathy with international normalized ratio of prothrombin time > 2.0 moderate to severe aortic regurgitation abdominal aortic aneurysm (>5 mm) or dissection arrhythmias that may interfere with triggering of eecp system (uncontrolled atrial fibrillation, flutter and very frequent premature ventricular contractions) heart rate of <35 or >125 beats per minute any surgical intervention within 6 weeks before eecp recent cardiac catheterization (1-2 weeks) or arterial femoral puncture severe peripheral arterial disease severe venous disease (thrombophlebitis, prior or current deep vein thrombosis or pulmonary embolism) severe chronic obstructive pulmonary disease pregnancy or women of childbearing age who do not have a negative pregnancy test

Number of arms
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

2

Funding
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

Sheba Medical Center

Inclusion age min
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

18

Inclusion age max
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

100

Countries
Last imported at : Dec. 1, 2023, 8 a.m.
Source : ClinicalTrials.gov

Israel

Type of patients
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

Patients recovered from covid

Severity scale
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

N/A

Total sample size
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

32

primary outcome
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

Change in fatigue score

Notes
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

None

Phase
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

Not reported

Arms
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

[{"arm_notes": "nan", "treatment_id": 2673, "treatment_name": "Enhanced external counterpulsation", "treatment_type": "Rehabilitation", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]